Press Room

Announces Presentation at the Pacific Growth Equities
2006 Life Sciences Growth Conference
June 14, 2006

Carlsbad, CA, May 24, 2006 -- bioTheranostics, a leader in molecular cancer profiling to enable personalized medicine, announced today that Antonius Schuh, Ph.D., the Company's Chief Executive Officer, will present at the Pacific Growth Equities 2006 Life Sciences Growth Conference on Wednesday, June 14, at 10:30 a.m. PDT in the Stanford Room of the InterContinental Mark Hopkins Hotel in San Francisco.

Dr. Schuh will provide an update on the exciting developments related to the company’s molecular cancer profiling technologies and business opportunities for tumor identification, patient prognosis and prediction of response to cancer therapies. In addition, he will address the company's development and commercial plans in the context of its commercial cancer diagnostic partnerships with Quest, LabCorp and Agendia.

About bioTheranostics
bioTheranostics, is focused on developing and commercializing molecular diagnostic technologies to enable personalized medicine in cancer treatment. As a leader in molecular cancer profiling technologies, bioTheranostics is targeting the oncology market with three first-in-class diagnostic technologies: Molecular Cancer Identification (MCID), Breast Cancer Profiling (BCP) and Drug Response Profiling (DRP).  To date, bioTheranostics has licensed its MCID and BCP technologies for specific clinical indications to Quest Diagnostics, Laboratory Corporation of America and Agendia BV in order to drive early market penetration and acceptance.  bioTheranostics, formerly Arcturus Bioscience, has recently relocated its headquarters from Mountain View, California, to Carlsbad, California. Please visit the bioTheranostics website at http://www.biotheranostics.com for more information.

About Pacific Growth Equities Life Sciences Growth Conference
Pacific Growth Equities, an investment bank specializing in emerging growth companies, is hosting its annual Life Sciences Growth Conference on June 12-14, 2006 at the InterContinental Mark Hopkins Hotel in San Francisco. Institutional investors, venture capitalists and life sciences industry insiders will focus on and interact with senior management from over 170 leading public and private companies with the highest growth potential in the second half of 2006 and beyond.

| TOP |